drugset / Trial / NCT00599001
Safety, Pharmacokinetics, and Pharmacodynamics of SD-101 in Healthy Normal Males
RandomizedParallel-groupSingle-blindTreatment
Summary
The main purpose of this study is to assess the safety, tolerability, and biological activity of SD-101 compared with placebo in healthy male volunteers.
Timeline
- Start
- 2008-01
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nelitolimod | Oligonucleotide (other) | — | Subcutaneous |
Indications
No indication recorded.